SKA31

CAS No. 40172-65-4

SKA31 ( SKA 31;SKA-31;Naphtho[12-d]thiazol-2-ylamine )

Catalog No. M20078 CAS No. 40172-65-4

SKA 31 is an activator of KCa3.1 and KCa2 channels (EC50s: 260 2900 2900 nM for KCa3.1 KCa2.1 and KCa2.2 respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 50 In Stock
10MG 72 In Stock
25MG 147 In Stock
50MG 290 In Stock
100MG 515 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SKA31
  • Note
    Research use only not for human use.
  • Brief Description
    SKA 31 is an activator of KCa3.1 and KCa2 channels (EC50s: 260 2900 2900 nM for KCa3.1 KCa2.1 and KCa2.2 respectively).
  • Description
    SKA 31 is an activator of KCa3.1 and KCa2 channels (EC50s: 260 2900 2900 nM for KCa3.1 KCa2.1 and KCa2.2 respectively).
  • Synonyms
    SKA 31;SKA-31;Naphtho[12-d]thiazol-2-ylamine
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    KCa3.1 channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    40172-65-4
  • Formula Weight
    200.26
  • Molecular Formula
    C11H8N2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 30 mg/mL (150 mM)
  • SMILES
    Nc1nc2c(ccc3ccccc23)s1
  • Chemical Name
    Naphtho[12-d]thiazol-2-ylamine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sankaranarayanan A Naphtho[12-d]thiazol-2-ylamine (SKA-31) a new activator of KCa2 and KCa3.1 potassium channels potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol. 2009 Feb;75(2):281-95.
molnova catalog
related products
  • Chlorzoxazone

    Chlorzoxazone is a centrally acting muscle relaxant used to treat muscle spasm and the resulting pain or discomfort.

  • BMS-813160

    BMS-813160 is the first dualCCR2/CCR5antagonist to enter Clinical development for cardiovascular.

  • BMS-191011

    BMS-191011 is an activator of large-conductance calcium-activated potassium (BKCa) channels effective in stroke models.